COVID-19

News

EU's COVID jab certificate scheme goes live in seven countri...

The first batch of EU countries have started recognising the vaccination status of travellers using digital vaccine certificates as the bloc moves towards

Views & Analysis

What HCPs think about blood clots linked to COVID-19 vaccine...

In the latest edition of What HCPs Think, CREATION.co's Laura Marsh looks at what healthcare professionals

News

Janssen J&J Johnson and Johnson pharmaceutical companies

Janssen COVID jab cleared in UK as fears of third wave mount

With concern already growing about a possible third wave of COVID-19 infections, the UK has cleared the use of a fourth vaccine from Johnson & Johnson's Janssen division.

Digital

The future of clinical trials innovation

Now what? The future of clinical trials after the pandemic

Sheila Rocchio highlights four key areas life sciences must improve on as an industry to drive real change in how clinical trials are conducted.

News

scientifically visualization of a coronavirus spike protein

GSK, Sanofi eye Q4 approval as COVID jab starts phase 3

GlaxoSmithKline's COVID-19 drive has advanced on two fronts, with the start of phase 3 trials of its Sanofi-partnered vaccine candidate as well as an FDA emergency approval for antibody sot

News

Belgium halts dosing of J&J COVID vaccine in under 41s after...

Belgium's Ministry of Health has paused dosing of people under the age of 41 with Johnson & Johnson's one-shot COVID-19 vaccine, following the death of a woman from what appeared to be

EU's COVID jab certificate scheme goes live in seven countri...

What HCPs think about blood clots linked to COVID-19 vaccine...

Janssen COVID jab cleared in UK as fears of third wave mount

Now what? The future of clinical trials after the pandemic

GSK, Sanofi eye Q4 approval as COVID jab starts phase 3

Belgium halts dosing of J&J COVID vaccine in under 41s after...

Novartis' new SMA gene therapy cleared in EU

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks